vs

Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $25.8M, roughly 1.4× First Bancorp, Inc). On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -57.1%). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -46.5%).

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FNLC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$37.2M
$25.8M
FNLC
Growing faster (revenue YoY)
FNLC
FNLC
+74.6% gap
FNLC
17.5%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FNLC
FNLC
Annualised
FNLC
18.1%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FNLC
FNLC
ORGO
ORGO
Revenue
$25.8M
$37.2M
Net Profit
$10.2M
Gross Margin
30.8%
Operating Margin
48.1%
-185.1%
Net Margin
39.4%
Revenue YoY
17.5%
-57.1%
Net Profit YoY
39.7%
EPS (diluted)
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNLC
FNLC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$25.8M
$225.6M
Q3 25
$24.5M
$150.9M
Q2 25
$22.5M
$101.0M
Q1 25
$21.8M
$86.7M
Q4 24
$22.0M
$126.7M
Q3 24
$20.5M
$115.2M
Q2 24
$19.2M
$130.2M
Net Profit
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$10.2M
$43.7M
Q3 25
$9.1M
$21.6M
Q2 25
$8.1M
$-9.4M
Q1 25
$7.1M
$-18.8M
Q4 24
$7.3M
$7.7M
Q3 24
$7.6M
$12.3M
Q2 24
$6.2M
$-17.0M
Gross Margin
FNLC
FNLC
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
FNLC
FNLC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
48.1%
28.1%
Q3 25
45.2%
13.7%
Q2 25
43.7%
-12.5%
Q1 25
39.3%
-30.9%
Q4 24
39.5%
8.1%
Q3 24
44.6%
5.4%
Q2 24
38.8%
-10.7%
Net Margin
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
39.4%
19.4%
Q3 25
37.0%
14.3%
Q2 25
35.8%
-9.3%
Q1 25
32.5%
-21.7%
Q4 24
33.1%
6.1%
Q3 24
36.9%
10.7%
Q2 24
32.1%
-13.1%
EPS (diluted)
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$0.91
$0.31
Q3 25
$0.81
$0.11
Q2 25
$0.72
$-0.10
Q1 25
$0.63
$-0.17
Q4 24
$0.66
$0.05
Q3 24
$0.68
$0.09
Q2 24
$0.55
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNLC
FNLC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
$95.5M
Stockholders' EquityBook value
$283.1M
Total Assets
$3.2B
$520.0M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNLC
FNLC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$95.5M
Q3 25
$95.5M
Q2 25
$95.0M
Q1 25
$70.0M
Q4 24
$95.0M
Q3 24
$95.0M
$62.3M
Q2 24
$70.0M
$63.8M
Stockholders' Equity
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$283.1M
$300.1M
Q3 25
$274.6M
$255.1M
Q2 25
$265.5M
$233.2M
Q1 25
$259.7M
$242.9M
Q4 24
$252.5M
$262.9M
Q3 24
$256.8M
$278.5M
Q2 24
$244.7M
$263.5M
Total Assets
FNLC
FNLC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$3.2B
$598.7M
Q3 25
$3.2B
$509.8M
Q2 25
$3.2B
$461.1M
Q1 25
$3.2B
$467.4M
Q4 24
$3.2B
$497.9M
Q3 24
$3.1B
$446.3M
Q2 24
$3.1B
$443.2M
Debt / Equity
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
0.34×
Q3 25
0.35×
Q2 25
0.36×
Q1 25
0.27×
Q4 24
0.38×
Q3 24
0.37×
0.22×
Q2 24
0.29×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNLC
FNLC
ORGO
ORGO
Operating Cash FlowLast quarter
$37.8M
Free Cash FlowOCF − Capex
$34.6M
FCF MarginFCF / Revenue
133.9%
Capex IntensityCapex / Revenue
12.5%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$37.8M
$39.4M
Q3 25
$12.9M
$3.1M
Q2 25
$7.4M
$-32.9M
Q1 25
$2.2M
$-19.9M
Q4 24
$26.0M
$10.9M
Q3 24
$9.8M
$8.7M
Q2 24
$6.4M
$4.7M
Free Cash Flow
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
$34.6M
$34.8M
Q3 25
$12.6M
$844.0K
Q2 25
$7.2M
$-36.5M
Q1 25
$828.0K
$-23.6M
Q4 24
$24.6M
$7.6M
Q3 24
$9.6M
$6.1M
Q2 24
$6.3M
$2.9M
FCF Margin
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
133.9%
15.4%
Q3 25
51.4%
0.6%
Q2 25
32.1%
-36.1%
Q1 25
3.8%
-27.2%
Q4 24
111.7%
6.0%
Q3 24
47.0%
5.3%
Q2 24
32.9%
2.2%
Capex Intensity
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
12.5%
2.1%
Q3 25
1.2%
1.5%
Q2 25
0.6%
3.6%
Q1 25
6.2%
4.2%
Q4 24
6.7%
2.7%
Q3 24
0.5%
2.2%
Q2 24
0.3%
1.4%
Cash Conversion
FNLC
FNLC
ORGO
ORGO
Q1 26
Q4 25
3.72×
0.90×
Q3 25
1.42×
0.14×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
1.43×
Q3 24
1.29×
0.71×
Q2 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons